Toggle navigation
Home
Search
Services
Blog
Contact
About
On Airway Anesthetic Gas Analyzer
O'Callaghan, Michael J.
Displaytech, Inc., Longmont, CO, United States
Search 6 grants from Michael O'Callaghan
Search grants from Displaytech, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mechanisms of T cell inflammation in obesity-induced type 2 diabetes
Understanding the Impacts of HLA-DO in vivo
Maternal Smoking: HPA and Epigenetic Pathways to Infant Neurobehavioral Deficits
Diabetic Vasculopathy and Mitochondrial eNOS
New Approaches for Protein Crystallization, Cryopreservation and Radiation Damage
Recently added grants:
Role of the cartilage endplate in spinal disc degeneration
Necroptotic genes in cancer cellular response to radiation
Studies of the initiation and progression of small cell lung cancer using cells derived by differentiation from human pluripotent stem cells
Optimal BET inhibitor combination therapies in triple negative breast cancer
Pathogenic mechanisms of sinonasal sarcoma, a novel gender dimorphic cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44HL053158-02
Application #
2029219
Study Section
Special Emphasis Panel (ZRG7-SSS-8 (01))
Project Start
1994-09-30
Project End
1998-03-31
Budget Start
1996-09-30
Budget End
1997-09-29
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Displaytech, Inc.
Department
Type
DUNS #
City
Longmont
State
CO
Country
United States
Zip Code
80503
Related projects
NIH 1997
R44 HL
On Airway Anesthetic Gas Analyzer
O'Callaghan, Michael J. / Displaytech, Inc.
NIH 1996
R44 HL
On Airway Anesthetic Gas Analyzer
O'Callaghan, Michael J. / Displaytech, Inc.
Comments
Be the first to comment on Michael O'Callaghan's grant